The ASCEND Study: Evaluating TMB-001 in the Treatment of RXLI or ARCI Ichthyosis
Clinical trial NCT05295732 · COMPLETED
Trial details
- NCT number
- NCT05295732
- Sponsor
- LEO Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-21
- Primary completion
- 2024-06-17
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.